Skip to main content

Table 2 Prediction of composite cardiac events in patients with NICM (model 1)

From: Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non‐ischemic cardiomyopathy

 

HR (95 % CIs)

p-value

Multiple LGE lesions

11.4 (1.5–92.0)

0.020

NYHA ≥ III

0.77 (0.16–4.2)

0.756

BNP

0.997 (0.994–0.999)

0.017

Creatinine

81 (6–1122)

0.001

Furosemide

7.4 (0.9–68.3)

0.067

LGE size

1.9 (0.1–34.7)

0.658

LVESV

0.991 (0.970–1.013)

0.429

LVEF

0.995 (0.887–1.116)

0.925

  1. BNP brain natriuretic peptide, CIs confidence intervals, HR hazard ratio, LGE late gadolinium enhancement, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, NICM non-ischemic cardiomyopathy, NYHA New York Heart Association classification
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us